The calcineurin activity profiles of cyclosporin and tacrolimus are different in stable renal transplant patients

Transplant International

Volumn 19, Issue 10, 2006, Pages 821-827

  Koefoed Nielsen, Pernille B ^a   Karamperis, Nikolaos ^a   Højskov, Carsten ^a   Poulsen, Jørgen Hjelm ^a   Jørgensen, Kaj Anker ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Calcineurin activity; Cyclosporin; Pharmacodynamic monitoring; Tacrolimus

Indexed keywords

CALCINEURIN; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DOSE RESPONSE; DRUG ACTIVITY; DRUG INHIBITION; DRUG MECHANISM; DRUG MONITORING; ENZYME ACTIVITY; FEMALE; HUMAN; KIDNEY ALLOGRAFT; KIDNEY GRAFT; MALE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ADULT; AGED; CALCINEURIN; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PEPTIDES; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PROSPECTIVE STUDIES; TACROLIMUS; TIME FACTORS;

EID: 33748500590     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2006.00359.x     Document Type: Article

References (21)

1. Opelz G. Collaborative Transplant Study - 10-year report. Transplant Proc 1992; 24: 2342.
2. Hemenway CS, Heitman J. Calcineurin. Structure, function, and inhibition. Cell Biochem Biophys 1999; 30: 115.
3. Clipstone NA, Crabtree GR. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 1992; 357: 695.
4. Jorgensen KA, Koefoed-Nielsen PB, Karamperis N. Calcineurin phosphatase activity and immunosuppression. A review on the role of calcineurin phosphatase activity and the immunosuppressive effect of cyclosporin A and tacrolimus. Scand J Immunol 2003; 57: 93.
5. Vogel KW, Briesewitz R, Wandless TJ, Crabtree GR. Calcineurin inhibitors and the generalization of the presenting protein strategy. Adv Protein Chem 2001; 56: 253.
6. Karamperis N, Povlsen JV, Hojskov C, Poulsen JH, Pedersen AR, Jorgensen KA. Comparison of the pharmacokinetics of tacrolimus and cyclosporine at equivalent molecular doses. Transplant Proc 2003; 35: 1314.
7. Barshes NR, Goodpastor SE, Goss JA. Pharmacologic immunosuppression. Front Biosci 2004; 9: 411.
8. Yatscoff RW, Aspeslet LJ, Gallant HL. Pharmacodynamic monitoring of immunosuppressive drugs. Clin Chem 1998; 44: 428.
9. Caruso R, Perico N, Cattaneo D, et al. Whole-blood calcineurin activity is not predicted by cyclosporine blood concentration in renal transplant recipients. Clin Chem 2001; 47: 1679.
10. Halloran PF, Helms LM, Kung L, Noujaim J. The temporal profile of calcineurin inhibition by cyclosporine in vivo. Transplantation 1999; 68: 1356.
11. Koefoed-Nielsen PB, Gesualdo MB, Poulsen JH, Jorgensen KA. Blood tacrolimus levels and calcineurin phosphatase activity early after renal transplantation. Am J Transplant 2002; 2: 173.
12. Millan O, Brunet M, Campistol JM, et al. Pharmacodynamic approach to immunosuppressive therapies using calcineurin inhibitors and mycophenolate mofetil. Clin Chem 2003; 49: 1891.
13. Fruman DA, Klee CB, Bierer BE, Burakoff SJ. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A. Proc Natl Acad Sci USA 1992; 89: 3686.
14. Koefoed-Nielsen PB, Karamperis N, Jorgensen KA. Validation of the calcineurin phosphatase assay. Clin Chem 2004; 50: 2331.
15. Hesse CJ, Baan CC, Balk AH, Metselaar HJ, Weimar W, van Gelder T. Evaluation of the new EMIT enzyme immunoassay for the determination of whole-blood tacrolimus concentrations in kidney, heart, and liver transplant recipients. Transplant Proc 2002; 34: 2988.
16. Beresini MH, Davalian D, Alexander S, et al. Evaluation of EMIT cyclosporine assay for use with whole blood. Clin Chem 1993; 39(11 Pt 1): 2235.
17. Matsuda S, Shibasaki F, Takehana K, Mori H, Nishida E, Koyasu S. Two distinct action mechanisms of immunophilin-ligand complexes for the blockade of T-cell activation. EMBO Rep 2000; 1: 428.
18. Krummrei U, Baulieu EE, Chambraud B. The FKBP-associated protein FAP48 is an antiproliferative molecule and a player in T cell activation that increases IL2 synthesis. Proc Natl Acad Sci U S A 2003; 100: 2444.
19. Huai Q, Kim HY, Liu Y, et al. Crystal structure of calcineurin- cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes. Proc Natl Acad Sci U S A 2002; 99: 12037.
20. Kung L, Halloran PF. Immunophilins may limit calcineurin inhibition by cyclosporine and tacrolimus at high drug concentrations. Transplantation 2000; 70: 327.
21. Kramer BK, Montagnino G, Del Castillo D, et al. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Nephrol Dial Transplant 2005; 20: 968.